PodPitch
PodcastsRank #28744
Artwork for The Uromigos

The Uromigos

The Uromigos
Share:
MedicinePodcastsHealth & FitnessENunited-statesSeveral times per week
4.9 / 5
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
Top 57.5% by pitch volume (Rank #28744 of 50,000)Data updated Feb 10, 2026

Key Facts

Publishes
Several times per week
Episodes
472
Founded
N/A
Category
Medicine
Number of listeners
Private
Hidden on public pages

Listen to this Podcast

AppleSpotify
EpisodesMetricsListenersContactsSimilarFAQs
PreviousAesthetic Resistance PodcastRank #28743NextThe Debra Shepherd PodcastRank #28745
Pitch this podcast
Get the guest pitch kit.
Book a quick demo to unlock the outreach details you actually need before you hit send.
  • Verified contact + outreach fields
  • Exact listener estimates (not just bands)
  • Reply rate + response timing signals
10 minutes. Friendly walkthrough. No pressure.
Book a demo
Public snapshot
Audience: 4K–8K / month
Canonical: https://podpitch.com/podcasts/the-uromigos
Cadence: Active weekly
Reply rate: Under 2%

Latest Episodes

Back to top

Episode 475: Depth of Response and Overall Survival for IO-based Regimens in mRCC: Results of an FDA Analysis

Mon Feb 02 2026

Listen

In this Uromigos podcast episode, Brian and Tom engage with Elaine Chang from the FDA to discuss an analysis of depth of response as an indicator of survival in kidney cancer trials. They explore the FDA's data analysis process, the significance of tumor shrinkage, and the implications of their findings on treatment outcomes. The conversation delves into the limitations of current measurement methods and the potential for using depth of response as an early signal in drug development.

More

In this Uromigos podcast episode, Brian and Tom engage with Elaine Chang from the FDA to discuss an analysis of depth of response as an indicator of survival in kidney cancer trials. They explore the FDA's data analysis process, the significance of tumor shrinkage, and the implications of their findings on treatment outcomes. The conversation delves into the limitations of current measurement methods and the potential for using depth of response as an early signal in drug development.

Key Metrics

Back to top
Pitches sent
11
From PodPitch users
Rank
#28744
Top 57.5% by pitch volume (Rank #28744 of 50,000)
Average rating
4.9
Ratings count may be unavailable
Reviews
5
Written reviews (when available)
Publish cadence
Several times per week
Active weekly
Episode count
472
Data updated
Feb 10, 2026
Social followers
7.9K

Public Snapshot

Back to top
MedicinePodcastsHealth & Fitness
Country
United States
Language
English
Language (ISO)
Release cadence
Several times per week
Latest episode date
Mon Feb 02 2026

Audience & Outreach (Public)

Back to top
Audience range
4K–8K / month
Public band
Reply rate band
Under 2%
Public band
Response time band
2–4 weeks
Public band
Replies received
1–5
Public band

Public ranges are rounded for privacy. Unlock the full report for exact values.

Presence & Signals

Back to top
Social followers
7.9K
Contact available
Yes
Masked on public pages
Sponsors detected
Yes
Guest format
No

Social links

No public profiles listed.

Demo to Unlock Full Outreach Intelligence

We publicly share enough context for discovery. For actionable outreach data, unlock the private blocks below.

Audience & Growth
Demo to unlock
Monthly listeners49,360
Reply rate18.2%
Avg response4.1 days
See audience size and growth. Demo to unlock.
Contact preview
t***@hidden
Get verified host contact details. Demo to unlock.
Sponsor signals
Demo to unlock
Sponsor mentionsLikely
Ad-read historyAvailable
View sponsorship signals and ad read history. Demo to unlock.
Book a demo

How To Pitch The Uromigos

Back to top

Want to get booked on podcasts like this?

Become the guest your future customers already trust.

PodPitch helps you find shows, draft personalized pitches, and hit send faster. We share enough public context for discovery; for actionable outreach data, unlock the private blocks.

  • Identify shows that match your audience and offer.
  • Write pitches in your voice (nothing sends without you).
  • Move from “maybe later” to booked interviews faster.
  • Unlock deeper outreach intelligence with a quick demo.

This show is Rank #28744 by pitch volume, with 11 pitches sent by PodPitch users.

Book a demoBrowse more shows10 minutes. Friendly walkthrough. No pressure.

Reviews

Back to top
4.9 / 5
RatingsN/A
Written reviews5

We summarize public review counts here; full review text aggregation is not shown on PodPitch yet.

Frequently Asked Questions About The Uromigos

Back to top

What is The Uromigos about?

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

How often does The Uromigos publish new episodes?

Several times per week

How many listeners does The Uromigos get?

PodPitch shows a public audience band (like "4K–8K / month"). Book a demo to unlock exact audience estimates and how we calculate them.

How can I pitch The Uromigos?

Use PodPitch to access verified outreach details and pitch recommendations for The Uromigos. Start at https://podpitch.com/try/1.

Which podcasts are similar to The Uromigos?

This page includes internal links to similar podcasts. You can also browse the full directory at https://podpitch.com/podcasts.

How do I contact The Uromigos?

Public pages only show a masked contact preview. Book a demo to unlock verified email and outreach fields.

Quick favor for your future self: want podcast bookings without the extra mental load? PodPitch helps you find shows, draft personalized pitches, and hit send faster.

Book a demoBrowse more shows